logo

Marinus Pharmaceuticals Inc’s Shares Reel: 39.71% Quarterly Revenue Decline Amid 104.65M Market Cap

ZM Stock

The market performance of Marinus Pharmaceuticals Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $11.26 on 01/08/24, while the lowest value for the same duration was $1.05 on 08/14/24.

52-week price history of MRNS Stock

Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Marinus Pharmaceuticals Inc’s current trading price is -83.13% away from its 52-week high, while its distance from the 52-week low is 80.95%. The stock’s price range during the 52-week period has remained between $1.05 and $11.26. In the Healthcare sector, the company’s shares saw a trading volume of around 2.97 million for the day, which was evidently higher than the average daily volume of 0.66 million over the past three months.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Market Capitalization and Financial Performance: An In-Depth Look

Marinus Pharmaceuticals Inc (MRNS) has experienced a quarterly rise of 39.71% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 104.65M and boasts a workforce of 165 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.3854, with a change in price of +0.4300. Similarly, Marinus Pharmaceuticals Inc recorded 860,484 in trading volume during the last 100 days, posting a change of +29.25%.

MRNS Stock Stochastic Average

Marinus Pharmaceuticals Inc’s raw stochastic average for the past 50 days is presently 92.39%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 88.89%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 82.34% and 84.05%, respectively.

MRNS Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. This year’s metric has recorded a Price decrease of -82.52%. However, over the past six months, we’ve seen a stronger performance of -78.72%. The price of MRNS fallen by 46.15% over the last 30 days. And in the last five days, it has surged by 22.58%.

Most Popular